Rank | Gene Set | Z-score |
---|---|---|
1 | protein heterotrimerization (GO:0070208) | 6.80201997 |
2 | collagen fibril organization (GO:0030199) | 6.27811434 |
3 | regulation of mononuclear cell migration (GO:0071675) | 5.48893278 |
4 | barbed-end actin filament capping (GO:0051016) | 5.22711445 |
5 | skin morphogenesis (GO:0043589) | 5.01359036 |
6 | extracellular fibril organization (GO:0043206) | 4.77506666 |
7 | virion attachment to host cell (GO:0019062) | 4.76979746 |
8 | adhesion of symbiont to host cell (GO:0044650) | 4.76979746 |
9 | chondrocyte proliferation (GO:0035988) | 4.67821241 |
10 | bone trabecula formation (GO:0060346) | 4.54551013 |
11 | cardiac myofibril assembly (GO:0055003) | 4.51860377 |
12 | plasma membrane repair (GO:0001778) | 4.49668313 |
13 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.49044868 |
14 | endodermal cell differentiation (GO:0035987) | 4.45762473 |
15 | adhesion of symbiont to host (GO:0044406) | 4.38496014 |
16 | regulation of macrophage chemotaxis (GO:0010758) | 4.27296943 |
17 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.26433467 |
18 | collagen metabolic process (GO:0032963) | 4.24409148 |
19 | collagen catabolic process (GO:0030574) | 4.17732570 |
20 | fibril organization (GO:0097435) | 4.17639569 |
21 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.99569933 |
22 | negative regulation of interleukin-12 production (GO:0032695) | 3.98396183 |
23 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.97409724 |
24 | gonadal mesoderm development (GO:0007506) | 3.86836145 |
25 | multicellular organismal catabolic process (GO:0044243) | 3.82051862 |
26 | glycosphingolipid catabolic process (GO:0046479) | 3.81317702 |
27 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.78338032 |
28 | axon extension involved in axon guidance (GO:0048846) | 3.78338032 |
29 | multicellular organismal metabolic process (GO:0044236) | 3.74645041 |
30 | basement membrane organization (GO:0071711) | 3.71600983 |
31 | negative regulation of fatty acid transport (GO:2000192) | 3.69515804 |
32 | epithelial cell-cell adhesion (GO:0090136) | 3.69290318 |
33 | extracellular matrix assembly (GO:0085029) | 3.63602708 |
34 | myofibril assembly (GO:0030239) | 3.57824201 |
35 | amino sugar catabolic process (GO:0046348) | 3.55761163 |
36 | extracellular matrix disassembly (GO:0022617) | 3.51619477 |
37 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.47796276 |
38 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.43932643 |
39 | response to peptidoglycan (GO:0032494) | 3.42385633 |
40 | cellular response to cadmium ion (GO:0071276) | 3.40331513 |
41 | metanephric mesenchyme development (GO:0072075) | 3.38948265 |
42 | glycolipid catabolic process (GO:0019377) | 3.38440516 |
43 | sarcomere organization (GO:0045214) | 3.36641777 |
44 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.35391945 |
45 | dermatan sulfate biosynthetic process (GO:0030208) | 3.34181463 |
46 | actin-myosin filament sliding (GO:0033275) | 3.33868410 |
47 | muscle filament sliding (GO:0030049) | 3.33868410 |
48 | cell adhesion mediated by integrin (GO:0033627) | 3.33789318 |
49 | cellular response to zinc ion (GO:0071294) | 3.30194067 |
50 | glomerular basement membrane development (GO:0032836) | 3.30139224 |
51 | keratan sulfate catabolic process (GO:0042340) | 3.29493369 |
52 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.25487207 |
53 | trabecula formation (GO:0060343) | 3.25313698 |
54 | response to thyroid hormone (GO:0097066) | 3.24657596 |
55 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.24466764 |
56 | oligosaccharide catabolic process (GO:0009313) | 3.23719737 |
57 | stress fiber assembly (GO:0043149) | 3.20999310 |
58 | endothelial cell chemotaxis (GO:0035767) | 3.19772246 |
59 | detection of molecule of bacterial origin (GO:0032490) | 3.19383524 |
60 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.14773457 |
61 | eosinophil chemotaxis (GO:0048245) | 3.12451438 |
62 | protein localization to endosome (GO:0036010) | 3.09123469 |
63 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.09006745 |
64 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.08331990 |
65 | peripheral nervous system axon ensheathment (GO:0032292) | 3.05103572 |
66 | myelination in peripheral nervous system (GO:0022011) | 3.05103572 |
67 | kidney mesenchyme development (GO:0072074) | 3.04431350 |
68 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.03469861 |
69 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.02954787 |
70 | actin-mediated cell contraction (GO:0070252) | 3.00736126 |
71 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.00654057 |
72 | dermatan sulfate metabolic process (GO:0030205) | 3.00152869 |
73 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.99695780 |
74 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.97381658 |
75 | endocardial cushion development (GO:0003197) | 2.94791071 |
76 | ceramide catabolic process (GO:0046514) | 2.94234155 |
77 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93943699 |
78 | actomyosin structure organization (GO:0031032) | 2.93163633 |
79 | * extracellular matrix organization (GO:0030198) | 2.92275537 |
80 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.92007184 |
81 | positive regulation of receptor recycling (GO:0001921) | 2.91911126 |
82 | N-acetylneuraminate metabolic process (GO:0006054) | 2.91652924 |
83 | venous blood vessel morphogenesis (GO:0048845) | 2.91573624 |
84 | * extracellular structure organization (GO:0043062) | 2.91299203 |
85 | glial cell migration (GO:0008347) | 2.90286861 |
86 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.89529112 |
87 | muscle cell fate commitment (GO:0042693) | 2.87967782 |
88 | heart trabecula formation (GO:0060347) | 2.87004343 |
89 | peptidyl-proline hydroxylation (GO:0019511) | 2.86082166 |
90 | macrophage differentiation (GO:0030225) | 2.85002251 |
91 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.84872403 |
92 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.81655705 |
93 | pinocytosis (GO:0006907) | 2.81071827 |
94 | wound healing, spreading of epidermal cells (GO:0035313) | 2.80850342 |
95 | regulation of podosome assembly (GO:0071801) | 2.80831944 |
96 | apoptotic cell clearance (GO:0043277) | 2.80828450 |
97 | monocyte chemotaxis (GO:0002548) | 2.80619003 |
98 | macrophage activation involved in immune response (GO:0002281) | 2.79912585 |
99 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.78193226 |
100 | eosinophil migration (GO:0072677) | 2.76045465 |
101 | myoblast fusion (GO:0007520) | 2.75953878 |
102 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.75340618 |
103 | tooth mineralization (GO:0034505) | 2.74965971 |
104 | membrane lipid catabolic process (GO:0046466) | 2.74616506 |
105 | endothelial cell morphogenesis (GO:0001886) | 2.74615878 |
106 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.74254741 |
107 | atrioventricular valve morphogenesis (GO:0003181) | 2.73612921 |
108 | decidualization (GO:0046697) | 2.73119476 |
109 | regulation of cholesterol storage (GO:0010885) | 2.72802858 |
110 | atrial septum morphogenesis (GO:0060413) | 2.71930537 |
111 | regulation of monocyte chemotaxis (GO:0090025) | 2.71919317 |
112 | regulation of tight junction assembly (GO:2000810) | 2.71194150 |
113 | cell-matrix adhesion (GO:0007160) | 2.71130407 |
114 | neutrophil activation involved in immune response (GO:0002283) | 2.71041342 |
115 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.70475937 |
116 | positive regulation of fibroblast migration (GO:0010763) | 2.70160556 |
117 | craniofacial suture morphogenesis (GO:0097094) | 2.68472421 |
118 | cell migration involved in heart development (GO:0060973) | 2.67144333 |
119 | substrate-dependent cell migration (GO:0006929) | 2.67037175 |
120 | cellular response to vitamin (GO:0071295) | 2.66758516 |
121 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.66614019 |
122 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.65942433 |
123 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65565223 |
124 | protein hydroxylation (GO:0018126) | 2.65181627 |
125 | establishment of nucleus localization (GO:0040023) | 2.65043126 |
126 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.64879101 |
127 | actin filament-based movement (GO:0030048) | 2.63778172 |
128 | peptide catabolic process (GO:0043171) | 2.63510743 |
129 | chondrocyte development (GO:0002063) | 2.63363117 |
130 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.62493936 |
131 | positive regulation of heat generation (GO:0031652) | 2.61972237 |
132 | positive regulation of cholesterol efflux (GO:0010875) | 2.61407420 |
133 | syncytium formation (GO:0006949) | 2.61164738 |
134 | adenosine receptor signaling pathway (GO:0001973) | 2.60115963 |
135 | regulation of early endosome to late endosome transport (GO:2000641) | 2.59874136 |
136 | T-helper 1 type immune response (GO:0042088) | 2.59665682 |
137 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.58034641 |
138 | glomerular filtration (GO:0003094) | 2.57738919 |
139 | cellular response to amino acid stimulus (GO:0071230) | 2.57427871 |
140 | protein targeting to plasma membrane (GO:0072661) | 2.55358708 |
141 | endochondral ossification (GO:0001958) | 2.54621565 |
142 | replacement ossification (GO:0036075) | 2.54621565 |
143 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.53909952 |
144 | positive regulation of osteoblast proliferation (GO:0033690) | 2.53327628 |
145 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.51934450 |
146 | sphingolipid catabolic process (GO:0030149) | 2.51700091 |
147 | chondroitin sulfate catabolic process (GO:0030207) | 2.51621325 |
148 | organ induction (GO:0001759) | 2.51590143 |
149 | cell-substrate adhesion (GO:0031589) | 2.50771357 |
150 | negative regulation of cartilage development (GO:0061037) | 2.50596932 |
151 | cardiac muscle cell development (GO:0055013) | 2.50381074 |
152 | positive regulation of fat cell differentiation (GO:0045600) | 2.49942067 |
153 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.48873812 |
154 | regulation of fever generation (GO:0031620) | 2.48052051 |
155 | positive regulation of leukocyte degranulation (GO:0043302) | 2.47592531 |
156 | negative regulation of heart growth (GO:0061117) | 2.47262038 |
157 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.47262038 |
158 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.45893936 |
159 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.44663512 |
160 | protein localization to cell surface (GO:0034394) | 2.44531731 |
161 | mannose metabolic process (GO:0006013) | 2.44421617 |
162 | positive regulation of extracellular matrix organization (GO:1903055) | 2.43326426 |
163 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.42602191 |
164 | phagocytosis, engulfment (GO:0006911) | 2.41188552 |
165 | immunoglobulin mediated immune response (GO:0016064) | 2.40255959 |
166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39194574 |
167 | regulation of chemokine biosynthetic process (GO:0045073) | 2.39126439 |
168 | low-density lipoprotein particle clearance (GO:0034383) | 2.38854211 |
169 | phagocytosis, recognition (GO:0006910) | 2.38611294 |
170 | cortical actin cytoskeleton organization (GO:0030866) | 2.37890800 |
171 | negative regulation of monooxygenase activity (GO:0032769) | 2.37109191 |
172 | positive regulation by symbiont of host defense response (GO:0052509) | 2.37040531 |
173 | modulation by symbiont of host defense response (GO:0052031) | 2.37040531 |
174 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.37040531 |
175 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.37040531 |
176 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.37040531 |
177 | modulation by symbiont of host immune response (GO:0052553) | 2.37040531 |
178 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.36031811 |
179 | regulation of vitamin metabolic process (GO:0030656) | 2.35358616 |
180 | glycosaminoglycan catabolic process (GO:0006027) | 2.35190450 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 5.46409123 |
2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.68392099 |
3 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.58874066 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.54886934 |
5 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.90301934 |
6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.81451864 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.70456837 |
8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67210806 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.66727128 |
10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64781699 |
11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.60577771 |
12 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.54532776 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52881141 |
14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.49823552 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.43456887 |
16 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.41769164 |
17 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.39104662 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29788604 |
19 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.29433954 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24772169 |
21 | * CJUN_26792858_Chip-Seq_BT549_Human | 2.24708024 |
22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23408190 |
23 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.21038274 |
24 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.19693323 |
25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.13554973 |
26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.10242170 |
27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10106554 |
28 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.05203340 |
29 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.01608359 |
30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.99745300 |
31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.99745300 |
32 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.91305481 |
33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85650399 |
34 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.84695553 |
35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83603624 |
36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.82491454 |
37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.82491454 |
38 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.75957662 |
39 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75421421 |
40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.74013813 |
41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.72810880 |
42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.70352910 |
43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70070748 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70063398 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66870643 |
46 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.61933084 |
47 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.61933084 |
48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61028370 |
49 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.58117407 |
50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57588011 |
51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56926719 |
52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.56217748 |
53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53268687 |
54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53012860 |
55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.49819558 |
56 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.47977569 |
57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47436418 |
58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46641248 |
59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.43964221 |
60 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.43431404 |
61 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.42177232 |
62 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40933294 |
63 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40750696 |
64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38799553 |
65 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.36646389 |
66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35873037 |
67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35741876 |
68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35337715 |
69 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.33956993 |
70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33454862 |
71 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32820869 |
72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32812718 |
73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31794338 |
74 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31665811 |
75 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30547128 |
76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.29300616 |
77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29198055 |
78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28995826 |
79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28955317 |
80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28552066 |
81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27982755 |
82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.27902800 |
83 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24657589 |
84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24146354 |
85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20136135 |
86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19776873 |
87 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.18947250 |
88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18784244 |
89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18230852 |
90 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.18228772 |
91 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16360339 |
92 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16360339 |
93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16041386 |
94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15769617 |
95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14869829 |
96 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14728489 |
97 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14365218 |
98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13890083 |
99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13167864 |
100 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13046543 |
101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11570125 |
102 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.11050535 |
103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09840949 |
104 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.09440365 |
105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.07020187 |
106 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.06153471 |
107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06094992 |
108 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.06087084 |
109 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05716341 |
110 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.05329081 |
111 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.04612169 |
112 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04530358 |
113 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04326988 |
114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03162000 |
115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03058210 |
116 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02672810 |
117 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02470555 |
118 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02188183 |
119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02057285 |
120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01848416 |
121 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01457779 |
122 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00735815 |
123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00538108 |
124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99803739 |
125 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99781293 |
126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99345260 |
127 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99303447 |
128 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99133987 |
129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98996229 |
130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98942070 |
131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98163165 |
132 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97372242 |
133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97018734 |
134 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96715128 |
135 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95516680 |
136 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94731394 |
137 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.94286363 |
138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94237346 |
139 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94083718 |
140 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.93877012 |
141 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93842104 |
142 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93742052 |
143 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93423595 |
144 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93283797 |
145 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93113430 |
146 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92971070 |
147 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92533061 |
148 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92292893 |
149 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89749240 |
150 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87578643 |
151 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87012321 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 7.91290329 |
2 | MP0005503_abnormal_tendon_morphology | 5.28161719 |
3 | MP0005275_abnormal_skin_tensile | 5.11982124 |
4 | MP0005058_abnormal_lysosome_morphology | 4.40122993 |
5 | MP0003279_aneurysm | 3.48370225 |
6 | MP0000751_myopathy | 3.17816765 |
7 | MP0003705_abnormal_hypodermis_morpholog | 3.02828563 |
8 | MP0009840_abnormal_foam_cell | 2.94391808 |
9 | MP0004272_abnormal_basement_membrane | 2.91965899 |
10 | MP0005623_abnormal_meninges_morphology | 2.82569715 |
11 | MP0001958_emphysema | 2.80947651 |
12 | MP0003303_peritoneal_inflammation | 2.62255577 |
13 | MP0006082_CNS_inflammation | 2.60420645 |
14 | MP0003436_decreased_susceptibility_to | 2.33562300 |
15 | MP0002837_dystrophic_cardiac_calcinosis | 2.26872983 |
16 | MP0003172_abnormal_lysosome_physiology | 2.24835681 |
17 | MP0009384_cardiac_valve_regurgitation | 2.22891492 |
18 | MP0000604_amyloidosis | 2.21940223 |
19 | MP0002108_abnormal_muscle_morphology | 2.18437723 |
20 | MP0004084_abnormal_cardiac_muscle | 2.16439570 |
21 | MP0003300_gastrointestinal_ulcer | 2.06794078 |
22 | MP0006054_spinal_hemorrhage | 2.06115809 |
23 | MP0001533_abnormal_skeleton_physiology | 2.03663549 |
24 | MP0000749_muscle_degeneration | 2.02562687 |
25 | MP0002148_abnormal_hypersensitivity_rea | 2.02339410 |
26 | MP0003566_abnormal_cell_adhesion | 2.01635035 |
27 | MP0005257_abnormal_intraocular_pressure | 1.96852908 |
28 | MP0005508_abnormal_skeleton_morphology | 1.91379242 |
29 | MP0003075_altered_response_to | 1.91309957 |
30 | MP0005167_abnormal_blood-brain_barrier | 1.90006184 |
31 | MP0000750_abnormal_muscle_regeneration | 1.89860614 |
32 | MP0002419_abnormal_innate_immunity | 1.80470954 |
33 | MP0000733_abnormal_muscle_development | 1.78453454 |
34 | MP0003191_abnormal_cellular_cholesterol | 1.77210087 |
35 | MP0001542_abnormal_bone_strength | 1.75118226 |
36 | MP0009785_altered_susceptibility_to | 1.74601716 |
37 | MP0002060_abnormal_skin_morphology | 1.68522050 |
38 | MP0003448_altered_tumor_morphology | 1.64031041 |
39 | MP0004087_abnormal_muscle_fiber | 1.60703247 |
40 | MP0003091_abnormal_cell_migration | 1.57210519 |
41 | MP0000767_abnormal_smooth_muscle | 1.54126611 |
42 | MP0002295_abnormal_pulmonary_circulatio | 1.53162563 |
43 | MP0009250_abnormal_appendicular_skeleto | 1.43419120 |
44 | MP0003724_increased_susceptibility_to | 1.42809584 |
45 | MP0005023_abnormal_wound_healing | 1.41080276 |
46 | MP0000013_abnormal_adipose_tissue | 1.40844000 |
47 | MP0003385_abnormal_body_wall | 1.39267086 |
48 | MP0005330_cardiomyopathy | 1.38458505 |
49 | MP0006138_congestive_heart_failure | 1.38427614 |
50 | MP0010030_abnormal_orbit_morphology | 1.38241820 |
51 | MP0004145_abnormal_muscle_electrophysio | 1.38190883 |
52 | MP0004036_abnormal_muscle_relaxation | 1.38098374 |
53 | MP0002896_abnormal_bone_mineralization | 1.37071652 |
54 | MP0001299_abnormal_eye_distance/ | 1.36144480 |
55 | MP0003690_abnormal_glial_cell | 1.35658116 |
56 | MP0005369_muscle_phenotype | 1.35020385 |
57 | MP0003329_amyloid_beta_deposits | 1.34643981 |
58 | MP0000759_abnormal_skeletal_muscle | 1.33841597 |
59 | MP0001853_heart_inflammation | 1.32997423 |
60 | MP0005000_abnormal_immune_tolerance | 1.30814387 |
61 | MP0010368_abnormal_lymphatic_system | 1.30813732 |
62 | MP0002254_reproductive_system_inflammat | 1.30432130 |
63 | MP0001790_abnormal_immune_system | 1.29686197 |
64 | MP0005387_immune_system_phenotype | 1.29686197 |
65 | MP0009764_decreased_sensitivity_to | 1.28671610 |
66 | MP0004215_abnormal_myocardial_fiber | 1.26833867 |
67 | MP0002972_abnormal_cardiac_muscle | 1.25084629 |
68 | MP0003453_abnormal_keratinocyte_physiol | 1.24914753 |
69 | MP0001849_ear_inflammation | 1.24530997 |
70 | MP0003795_abnormal_bone_structure | 1.24321418 |
71 | MP0003045_fibrosis | 1.24279783 |
72 | MP0000747_muscle_weakness | 1.23915331 |
73 | MP0000858_altered_metastatic_potential | 1.23260973 |
74 | MP0002106_abnormal_muscle_physiology | 1.22845369 |
75 | MP0005025_abnormal_response_to | 1.21682326 |
76 | MP0005620_abnormal_muscle_contractility | 1.20063315 |
77 | MP0005164_abnormal_response_to | 1.19551534 |
78 | MP0003115_abnormal_respiratory_system | 1.17757210 |
79 | MP0000920_abnormal_myelination | 1.14202666 |
80 | MP0000685_abnormal_immune_system | 1.13396500 |
81 | MP0010630_abnormal_cardiac_muscle | 1.11455089 |
82 | MP0008775_abnormal_heart_ventricle | 1.10954872 |
83 | MP0004233_abnormal_muscle_weight | 1.09551431 |
84 | MP0001243_abnormal_dermal_layer | 1.08938153 |
85 | MP0004883_abnormal_blood_vessel | 1.08175598 |
86 | MP0002139_abnormal_hepatobiliary_system | 1.06961507 |
87 | MP0003950_abnormal_plasma_membrane | 1.05177698 |
88 | MP0001835_abnormal_antigen_presentation | 1.03586029 |
89 | MP0002234_abnormal_pharynx_morphology | 1.03503933 |
90 | MP0005390_skeleton_phenotype | 1.03316213 |
91 | MP0003283_abnormal_digestive_organ | 1.03010057 |
92 | MP0003828_pulmonary_edema | 1.02870231 |
93 | MP0001545_abnormal_hematopoietic_system | 1.01995205 |
94 | MP0005397_hematopoietic_system_phenotyp | 1.01995205 |
95 | MP0000534_abnormal_ureter_morphology | 1.01291801 |
96 | MP0002933_joint_inflammation | 1.01090641 |
97 | MP0004134_abnormal_chest_morphology | 1.00998950 |
98 | MP0002452_abnormal_antigen_presenting | 1.00693398 |
99 | MP0000428_abnormal_craniofacial_morphol | 1.00572031 |
100 | MP0001544_abnormal_cardiovascular_syste | 1.00224467 |
101 | MP0005385_cardiovascular_system_phenoty | 1.00224467 |
102 | MP0008260_abnormal_autophagy | 1.00074575 |
103 | MP0003634_abnormal_glial_cell | 0.99776871 |
104 | MP0002877_abnormal_melanocyte_morpholog | 0.99598685 |
105 | MP0002128_abnormal_blood_circulation | 0.98652649 |
106 | MP0002269_muscular_atrophy | 0.98242853 |
107 | MP0005165_increased_susceptibility_to | 0.97533317 |
108 | MP0010352_gastrointestinal_tract_polyps | 0.96740019 |
109 | MP0000163_abnormal_cartilage_morphology | 0.96598049 |
110 | MP0002282_abnormal_trachea_morphology | 0.96142175 |
111 | MP0008469_abnormal_protein_level | 0.95992901 |
112 | MP0004185_abnormal_adipocyte_glucose | 0.94151403 |
113 | MP0002115_abnormal_skeleton_extremities | 0.94101071 |
114 | MP0002932_abnormal_joint_morphology | 0.93049671 |
115 | MP0005595_abnormal_vascular_smooth | 0.90597402 |
116 | MP0001845_abnormal_inflammatory_respons | 0.89570082 |
117 | MP0003122_maternal_imprinting | 0.88915965 |
118 | MP0005671_abnormal_response_to | 0.88897245 |
119 | MP0000003_abnormal_adipose_tissue | 0.88883844 |
120 | MP0002168_other_aberrant_phenotype | 0.86861728 |
121 | MP0003942_abnormal_urinary_system | 0.85424939 |
122 | MP0004484_altered_response_of | 0.85379443 |
123 | MP0009780_abnormal_chondrocyte_physiolo | 0.85174655 |
124 | MP0008004_abnormal_stomach_pH | 0.85085095 |
125 | MP0005171_absent_coat_pigmentation | 0.85049892 |
126 | MP0001879_abnormal_lymphatic_vessel | 0.84430232 |
127 | MP0005166_decreased_susceptibility_to | 0.83693527 |
128 | MP0002405_respiratory_system_inflammati | 0.82593856 |
129 | MP0000249_abnormal_blood_vessel | 0.81931235 |
130 | MP0002998_abnormal_bone_remodeling | 0.80083485 |
131 | MP0002113_abnormal_skeleton_development | 0.79858040 |
132 | MP0001614_abnormal_blood_vessel | 0.79791563 |
133 | MP0005310_abnormal_salivary_gland | 0.79672650 |
134 | MP0002089_abnormal_postnatal_growth/wei | 0.79527177 |
135 | MP0002723_abnormal_immune_serum | 0.78823481 |
136 | MP0003935_abnormal_craniofacial_develop | 0.78411347 |
137 | MP0002925_abnormal_cardiovascular_devel | 0.78244864 |
138 | MP0005076_abnormal_cell_differentiation | 0.76457773 |
139 | MP0005388_respiratory_system_phenotype | 0.76316892 |
140 | MP0002133_abnormal_respiratory_system | 0.76316892 |
141 | MP0004947_skin_inflammation | 0.75739751 |
142 | MP0000266_abnormal_heart_morphology | 0.75066731 |
143 | MP0004510_myositis | 0.72899471 |
144 | MP0003755_abnormal_palate_morphology | 0.71823124 |
145 | MP0003137_abnormal_impulse_conducting | 0.71133525 |
146 | MP0000343_altered_response_to | 0.70286615 |
147 | MP0005464_abnormal_platelet_physiology | 0.69203513 |
148 | MP0005375_adipose_tissue_phenotype | 0.69127204 |
149 | MP0004085_abnormal_heartbeat | 0.67793846 |
150 | MP0009053_abnormal_anal_canal | 0.67402091 |
151 | MP0002090_abnormal_vision | 0.66699233 |
152 | MP0005451_abnormal_body_composition | 0.63303606 |
153 | MP0004858_abnormal_nervous_system | 0.62928729 |
154 | MP0009278_abnormal_bone_marrow | 0.62908949 |
155 | MP0000432_abnormal_head_morphology | 0.62743386 |
156 | MP0001819_abnormal_immune_cell | 0.62288229 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Protrusio acetabuli (HP:0003179) | 7.52896619 |
2 | Premature rupture of membranes (HP:0001788) | 7.24897724 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.99474233 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.99474233 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.99474233 |
6 | Ankle contracture (HP:0006466) | 5.48001294 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.89173556 |
8 | Aortic dissection (HP:0002647) | 4.84776724 |
9 | Type 1 muscle fiber predominance (HP:0003803) | 4.81073124 |
10 | Increased connective tissue (HP:0009025) | 4.30726046 |
11 | Broad metatarsal (HP:0001783) | 4.26012928 |
12 | Soft skin (HP:0000977) | 4.22591396 |
13 | Dysostosis multiplex (HP:0000943) | 4.20563670 |
14 | Atrophic scars (HP:0001075) | 4.14654837 |
15 | Cerebral aneurysm (HP:0004944) | 4.11942045 |
16 | Shallow orbits (HP:0000586) | 4.00874266 |
17 | Spinal rigidity (HP:0003306) | 3.86925610 |
18 | Vacuolated lymphocytes (HP:0001922) | 3.85017807 |
19 | Bladder diverticulum (HP:0000015) | 3.84401415 |
20 | Follicular hyperkeratosis (HP:0007502) | 3.82351778 |
21 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.70479878 |
22 | Abnormality of dentin (HP:0010299) | 3.69339883 |
23 | Aortic aneurysm (HP:0004942) | 3.66285861 |
24 | Fragile skin (HP:0001030) | 3.62318085 |
25 | Peritonitis (HP:0002586) | 3.61318894 |
26 | Dilatation of the ascending aorta (HP:0005111) | 3.59353685 |
27 | Increased variability in muscle fiber diameter (HP:0003557) | 3.56273766 |
28 | Neurofibrillary tangles (HP:0002185) | 3.55398498 |
29 | Increased cerebral lipofuscin (HP:0011813) | 3.53643105 |
30 | Nuclear cataract (HP:0100018) | 3.46753736 |
31 | Slender build (HP:0001533) | 3.43551437 |
32 | Glomerulonephritis (HP:0000099) | 3.42414026 |
33 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.32190878 |
34 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.32190878 |
35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.32190878 |
36 | Muscle fiber splitting (HP:0003555) | 3.29479566 |
37 | Mitral valve prolapse (HP:0001634) | 3.27473040 |
38 | Mucopolysacchariduria (HP:0008155) | 3.21924268 |
39 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.21924268 |
40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.17265300 |
41 | Wormian bones (HP:0002645) | 3.16014943 |
42 | Loss of speech (HP:0002371) | 3.13210361 |
43 | Wrist flexion contracture (HP:0001239) | 3.10424626 |
44 | Genu recurvatum (HP:0002816) | 3.06340047 |
45 | Neonatal short-limb short stature (HP:0008921) | 3.05068236 |
46 | Disinhibition (HP:0000734) | 3.00681082 |
47 | Blue sclerae (HP:0000592) | 3.00082346 |
48 | Mutism (HP:0002300) | 2.97237273 |
49 | Complement deficiency (HP:0004431) | 2.96331965 |
50 | Biconcave vertebral bodies (HP:0004586) | 2.91962996 |
51 | Difficulty climbing stairs (HP:0003551) | 2.91811887 |
52 | Axonal loss (HP:0003447) | 2.91086850 |
53 | Abnormality of macrophages (HP:0004311) | 2.81223581 |
54 | Spontaneous hematomas (HP:0007420) | 2.78318888 |
55 | Cervical subluxation (HP:0003308) | 2.75846974 |
56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73469557 |
57 | Abnormality of the calf musculature (HP:0001430) | 2.70043327 |
58 | Vertebral compression fractures (HP:0002953) | 2.65240532 |
59 | Hyperextensible skin (HP:0000974) | 2.64975582 |
60 | Distal lower limb amyotrophy (HP:0008944) | 2.63688380 |
61 | Overgrowth (HP:0001548) | 2.55395098 |
62 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.55136224 |
63 | Cerebral inclusion bodies (HP:0100314) | 2.54260745 |
64 | Round ear (HP:0100830) | 2.50115242 |
65 | Abnormality of complement system (HP:0005339) | 2.49698212 |
66 | Asymmetric septal hypertrophy (HP:0001670) | 2.47958665 |
67 | Infantile muscular hypotonia (HP:0008947) | 2.46262018 |
68 | Joint stiffness (HP:0001387) | 2.44257857 |
69 | Bowel diverticulosis (HP:0005222) | 2.43047199 |
70 | Hyporeflexia of lower limbs (HP:0002600) | 2.40448431 |
71 | Aneurysm (HP:0002617) | 2.39863735 |
72 | Hematochezia (HP:0002573) | 2.38966137 |
73 | Osteolytic defects of the hand bones (HP:0009699) | 2.38416683 |
74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.38416683 |
75 | Vascular tortuosity (HP:0004948) | 2.36224706 |
76 | Abnormal delivery (HP:0001787) | 2.34844869 |
77 | Striae distensae (HP:0001065) | 2.34523282 |
78 | Right ventricular cardiomyopathy (HP:0011663) | 2.32740806 |
79 | Scapular winging (HP:0003691) | 2.31875857 |
80 | Sudden death (HP:0001699) | 2.31265523 |
81 | Joint laxity (HP:0001388) | 2.30328298 |
82 | Limb-girdle muscle weakness (HP:0003325) | 2.26087614 |
83 | Elbow flexion contracture (HP:0002987) | 2.25669117 |
84 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.24988448 |
85 | Arterial tortuosity (HP:0005116) | 2.18214160 |
86 | Recurrent abscess formation (HP:0002722) | 2.17866404 |
87 | Absent frontal sinuses (HP:0002688) | 2.17783176 |
88 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.17593594 |
89 | Amyloidosis (HP:0011034) | 2.15485621 |
90 | Lower limb amyotrophy (HP:0007210) | 2.15390206 |
91 | Venous abnormality (HP:0002624) | 2.15276854 |
92 | Recurrent bacterial skin infections (HP:0005406) | 2.14621413 |
93 | Thin bony cortex (HP:0002753) | 2.13006327 |
94 | Lipoatrophy (HP:0100578) | 2.12638121 |
95 | Broad ribs (HP:0000885) | 2.12332839 |
96 | Mitral regurgitation (HP:0001653) | 2.11888397 |
97 | Difficulty running (HP:0009046) | 2.08368621 |
98 | Venous insufficiency (HP:0005293) | 2.06635558 |
99 | Wide anterior fontanel (HP:0000260) | 2.06181481 |
100 | Generalized amyotrophy (HP:0003700) | 2.05910077 |
101 | Deviation of the hallux (HP:0010051) | 2.05391803 |
102 | Ulnar deviation of the wrist (HP:0003049) | 2.05054241 |
103 | Increased density of long bones (HP:0006392) | 2.04194878 |
104 | Ovoid vertebral bodies (HP:0003300) | 2.03749601 |
105 | Metaphyseal irregularity (HP:0003025) | 2.02947897 |
106 | EMG: myopathic abnormalities (HP:0003458) | 2.02858252 |
107 | Eczematoid dermatitis (HP:0000976) | 2.01763775 |
108 | Distal upper limb amyotrophy (HP:0007149) | 2.00363052 |
109 | Upper limb amyotrophy (HP:0009129) | 2.00363052 |
110 | Camptodactyly of toe (HP:0001836) | 2.00112016 |
111 | Spondylolisthesis (HP:0003302) | 1.98658716 |
112 | Muscle fiber inclusion bodies (HP:0100299) | 1.98136192 |
113 | Buphthalmos (HP:0000557) | 1.97360635 |
114 | Myocardial infarction (HP:0001658) | 1.97081972 |
115 | Aortic regurgitation (HP:0001659) | 1.96025091 |
116 | Hallux valgus (HP:0001822) | 1.95752364 |
117 | Hip contracture (HP:0003273) | 1.94058120 |
118 | Hypoventilation (HP:0002791) | 1.93349438 |
119 | Abnormality of the acetabulum (HP:0003170) | 1.93338587 |
120 | Atrial fibrillation (HP:0005110) | 1.93274027 |
121 | Retinal atrophy (HP:0001105) | 1.91890531 |
122 | Apathy (HP:0000741) | 1.91734488 |
123 | Osteoarthritis (HP:0002758) | 1.91375828 |
124 | Thin ribs (HP:0000883) | 1.91297818 |
125 | Mesomelia (HP:0003027) | 1.91030621 |
126 | Calf muscle hypertrophy (HP:0008981) | 1.90603349 |
127 | Nephritis (HP:0000123) | 1.87202551 |
128 | Mild short stature (HP:0003502) | 1.87128220 |
129 | Tibial bowing (HP:0002982) | 1.86918778 |
130 | Diminished motivation (HP:0000745) | 1.86546518 |
131 | Upper motor neuron abnormality (HP:0002127) | 1.86018336 |
132 | Knee flexion contracture (HP:0006380) | 1.85445699 |
133 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85415210 |
134 | Pathologic fracture (HP:0002756) | 1.85341025 |
135 | Bell-shaped thorax (HP:0001591) | 1.84712686 |
136 | Short nail (HP:0001799) | 1.83049728 |
137 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.82839250 |
138 | Primary atrial arrhythmia (HP:0001692) | 1.81723094 |
139 | Flat cornea (HP:0007720) | 1.81184520 |
140 | Breech presentation (HP:0001623) | 1.79420787 |
141 | Nonimmune hydrops fetalis (HP:0001790) | 1.78730041 |
142 | Alopecia of scalp (HP:0002293) | 1.77825521 |
143 | Purpura (HP:0000979) | 1.77391318 |
144 | Pulmonary artery stenosis (HP:0004415) | 1.77123950 |
145 | Femoral bowing (HP:0002980) | 1.76339223 |
146 | Inguinal hernia (HP:0000023) | 1.75866856 |
147 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75532350 |
148 | Short hallux (HP:0010109) | 1.75414524 |
149 | Ulnar bowing (HP:0003031) | 1.75108215 |
150 | Calcaneovalgus deformity (HP:0001848) | 1.75010388 |
151 | Flared iliac wings (HP:0002869) | 1.74956084 |
152 | Supraventricular arrhythmia (HP:0005115) | 1.74721149 |
153 | Spinal cord lesions (HP:0100561) | 1.74676249 |
154 | Abnormality of skull ossification (HP:0002703) | 1.71054060 |
155 | Conjunctival telangiectasia (HP:0000524) | 1.69890203 |
156 | Bone pain (HP:0002653) | 1.68297474 |
157 | Cupped ribs (HP:0000887) | 1.67867985 |
158 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.67832503 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 4.78568320 |
2 | TRIB3 | 4.01561984 |
3 | DDR2 | 3.83094810 |
4 | PDGFRA | 3.54811496 |
5 | BLK | 3.32251144 |
6 | PKN2 | 2.80341983 |
7 | IRAK3 | 2.78789263 |
8 | MYLK | 2.76633741 |
9 | DMPK | 2.57978175 |
10 | RIPK1 | 2.28239780 |
11 | FER | 2.15249890 |
12 | PTK2B | 2.10220340 |
13 | NME2 | 2.02632985 |
14 | LATS1 | 2.02133260 |
15 | GRK7 | 1.96758786 |
16 | LATS2 | 1.95840124 |
17 | MAP3K14 | 1.88258193 |
18 | TYK2 | 1.77094940 |
19 | OBSCN | 1.76350447 |
20 | TBK1 | 1.75721738 |
21 | PAK2 | 1.75201164 |
22 | TAOK2 | 1.67614869 |
23 | ERN1 | 1.67454300 |
24 | TRPM7 | 1.64512694 |
25 | PAK3 | 1.63926251 |
26 | MAP3K13 | 1.62696779 |
27 | CSK | 1.61010567 |
28 | EPHB1 | 1.59254944 |
29 | EPHB2 | 1.56734150 |
30 | NTRK3 | 1.52895905 |
31 | MOS | 1.52349597 |
32 | TGFBR2 | 1.51036397 |
33 | MAP3K3 | 1.48098715 |
34 | PDGFRB | 1.44071496 |
35 | EPHA3 | 1.44042485 |
36 | MATK | 1.43917402 |
37 | CSF1R | 1.43832055 |
38 | SIK1 | 1.42879653 |
39 | ILK | 1.42607977 |
40 | BMX | 1.37130494 |
41 | FGFR4 | 1.33840489 |
42 | ROCK1 | 1.31863603 |
43 | PTK2 | 1.31506404 |
44 | PRKD3 | 1.30862069 |
45 | PAK4 | 1.29925818 |
46 | LIMK1 | 1.29517757 |
47 | KIT | 1.26963725 |
48 | PIK3CA | 1.17329744 |
49 | ROCK2 | 1.16756547 |
50 | FGFR1 | 1.16018609 |
51 | PTK6 | 1.13034272 |
52 | TGFBR1 | 1.10289364 |
53 | MUSK | 1.09567597 |
54 | MAP3K6 | 1.08577144 |
55 | LMTK2 | 1.05059588 |
56 | MAP3K11 | 1.03259943 |
57 | MAP2K3 | 1.02497904 |
58 | TAOK1 | 1.01260879 |
59 | CDC42BPA | 0.98220133 |
60 | TNIK | 0.97720021 |
61 | ZAP70 | 0.96873877 |
62 | PIK3CG | 0.96059148 |
63 | PLK2 | 0.95829140 |
64 | MET | 0.95078978 |
65 | EPHA4 | 0.94499130 |
66 | STK3 | 0.93926119 |
67 | RET | 0.93921533 |
68 | ARAF | 0.92291306 |
69 | PIM2 | 0.91310281 |
70 | TESK1 | 0.91159755 |
71 | MAP2K1 | 0.89994515 |
72 | DAPK3 | 0.85641871 |
73 | MAP3K10 | 0.83054775 |
74 | MAPK7 | 0.82683062 |
75 | NTRK1 | 0.80753712 |
76 | PAK6 | 0.79591244 |
77 | MTOR | 0.79250350 |
78 | TYRO3 | 0.78228618 |
79 | JAK3 | 0.77171927 |
80 | IKBKB | 0.76978492 |
81 | PRKCH | 0.75670939 |
82 | CAMK1D | 0.74929460 |
83 | STK24 | 0.74511735 |
84 | STK38L | 0.72529177 |
85 | PRKD1 | 0.72500426 |
86 | PDK4 | 0.72410871 |
87 | PDK3 | 0.72410871 |
88 | LRRK2 | 0.71546343 |
89 | ICK | 0.69923914 |
90 | PDK2 | 0.66367775 |
91 | FGFR2 | 0.65672067 |
92 | CAMKK2 | 0.65135664 |
93 | FES | 0.64402373 |
94 | ADRBK2 | 0.62468494 |
95 | MARK2 | 0.61922348 |
96 | CAMKK1 | 0.61391528 |
97 | CAMK2D | 0.60684142 |
98 | IKBKE | 0.59830586 |
99 | RPS6KC1 | 0.59311781 |
100 | RPS6KL1 | 0.59311781 |
101 | LYN | 0.58910313 |
102 | IRAK4 | 0.58646349 |
103 | KSR2 | 0.57931857 |
104 | RIPK4 | 0.55920348 |
105 | MAPKAPK3 | 0.54591210 |
106 | MAP3K1 | 0.54228840 |
107 | PHKG1 | 0.54172194 |
108 | PHKG2 | 0.54172194 |
109 | INSR | 0.54143838 |
110 | ERBB3 | 0.53554943 |
111 | SIK2 | 0.53527534 |
112 | CAMK1G | 0.52372027 |
113 | NEK9 | 0.52278130 |
114 | CDK15 | 0.51514830 |
115 | ABL1 | 0.50802755 |
116 | PRKD2 | 0.50591619 |
117 | MAPK4 | 0.50590830 |
118 | PRKG2 | 0.50588051 |
119 | CDK14 | 0.49570727 |
120 | PRPF4B | 0.49455114 |
121 | CDK18 | 0.49443036 |
122 | EEF2K | 0.47188786 |
123 | ACVR1B | 0.47017085 |
124 | MAP3K7 | 0.45015560 |
125 | CHUK | 0.43571661 |
126 | WNK1 | 0.42637902 |
127 | SRC | 0.42470850 |
128 | PRKCE | 0.41974316 |
129 | RPS6KA2 | 0.40954967 |
130 | FRK | 0.40947521 |
131 | RPS6KA6 | 0.40266850 |
132 | TIE1 | 0.40167594 |
133 | ABL2 | 0.40098901 |
134 | FGFR3 | 0.39789289 |
135 | CAMK2A | 0.38178178 |
136 | CDK11A | 0.38025304 |
137 | JAK2 | 0.36901522 |
138 | PDPK1 | 0.36791882 |
139 | CAMK2G | 0.36082431 |
140 | CLK1 | 0.35965940 |
141 | KSR1 | 0.35857811 |
142 | GSK3A | 0.35628163 |
143 | MAP3K4 | 0.34862533 |
144 | PAK1 | 0.32104576 |
145 | ADRBK1 | 0.31620151 |
146 | MAPK12 | 0.30809693 |
147 | JAK1 | 0.30584371 |
148 | CDK6 | 0.30118754 |
149 | CDK12 | 0.28417415 |
150 | FGR | 0.27493458 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.15020983 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.11596647 |
3 | Lysosome_Homo sapiens_hsa04142 | 3.35750980 |
4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.14340058 |
5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.14108607 |
6 | Focal adhesion_Homo sapiens_hsa04510 | 3.06008218 |
7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.99261862 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.98091360 |
9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.66654584 |
10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.59720253 |
11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.36144369 |
12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33299696 |
13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.20328789 |
14 | Amoebiasis_Homo sapiens_hsa05146 | 2.09932286 |
15 | Pertussis_Homo sapiens_hsa05133 | 2.08349085 |
16 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.92548747 |
17 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.90875552 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85183481 |
19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.84283706 |
20 | Prion diseases_Homo sapiens_hsa05020 | 1.77495300 |
21 | Tuberculosis_Homo sapiens_hsa05152 | 1.76377799 |
22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.76216367 |
23 | Adherens junction_Homo sapiens_hsa04520 | 1.69901499 |
24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.68185829 |
25 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.60996059 |
26 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.59309694 |
27 | Malaria_Homo sapiens_hsa05144 | 1.50442018 |
28 | Asthma_Homo sapiens_hsa05310 | 1.48689779 |
29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48027234 |
30 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.42979526 |
31 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.38835872 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37362219 |
33 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.35504832 |
34 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.34199226 |
35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34183774 |
36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33996700 |
37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.32711807 |
38 | Bladder cancer_Homo sapiens_hsa05219 | 1.31409393 |
39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30715184 |
40 | Mineral absorption_Homo sapiens_hsa04978 | 1.29930780 |
41 | Axon guidance_Homo sapiens_hsa04360 | 1.29868466 |
42 | Glioma_Homo sapiens_hsa05214 | 1.29619124 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.29178023 |
44 | Allograft rejection_Homo sapiens_hsa05330 | 1.27573366 |
45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24517923 |
46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24192037 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21641490 |
48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21206057 |
49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17761314 |
50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17372129 |
51 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.15483489 |
52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.12611281 |
53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10622113 |
54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10391295 |
55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10083586 |
56 | Platelet activation_Homo sapiens_hsa04611 | 1.09669464 |
57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.09371863 |
58 | Tight junction_Homo sapiens_hsa04530 | 1.09013280 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.08051357 |
60 | Melanoma_Homo sapiens_hsa05218 | 1.07574669 |
61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05348455 |
62 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.04614993 |
63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03649095 |
64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02821549 |
65 | Gap junction_Homo sapiens_hsa04540 | 1.01056350 |
66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.00415695 |
67 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00116617 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99569273 |
69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99437880 |
70 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.99215041 |
71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99140522 |
72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97696319 |
73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95926614 |
74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95907626 |
75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92832202 |
76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92386801 |
77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91612799 |
78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91268287 |
79 | Melanogenesis_Homo sapiens_hsa04916 | 0.91158262 |
80 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.87577611 |
81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87006609 |
82 | Pathways in cancer_Homo sapiens_hsa05200 | 0.85280036 |
83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83782986 |
84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.83538036 |
85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83133194 |
86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82447422 |
87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.82055758 |
88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81109216 |
89 | Renin secretion_Homo sapiens_hsa04924 | 0.80671113 |
90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80030534 |
91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79724171 |
92 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79096183 |
93 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77379275 |
94 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77216883 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.76903248 |
96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76741177 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.76730434 |
98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76636597 |
99 | Influenza A_Homo sapiens_hsa05164 | 0.75664844 |
100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74939766 |
101 | Salmonella infection_Homo sapiens_hsa05132 | 0.74889788 |
102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73277422 |
103 | Shigellosis_Homo sapiens_hsa05131 | 0.72537537 |
104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70807484 |
105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70610957 |
106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68848554 |
107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68795676 |
108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68774572 |
109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68621813 |
110 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68160584 |
111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67803170 |
112 | Phagosome_Homo sapiens_hsa04145 | 0.67281383 |
113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66833578 |
114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66517525 |
115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65872760 |
116 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65543829 |
117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65235434 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64036001 |
119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63957644 |
120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63692254 |
121 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63141905 |
122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62791418 |
123 | Endocytosis_Homo sapiens_hsa04144 | 0.62383792 |
124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61784550 |
125 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61347217 |
126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59490186 |
127 | Apoptosis_Homo sapiens_hsa04210 | 0.59388942 |
128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59101168 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58826277 |
130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58335003 |
131 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58251404 |
132 | Hepatitis C_Homo sapiens_hsa05160 | 0.58185658 |
133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58169319 |
134 | Hepatitis B_Homo sapiens_hsa05161 | 0.57958008 |
135 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56651084 |
136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56570673 |
137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.56102027 |
138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55990783 |
139 | Salivary secretion_Homo sapiens_hsa04970 | 0.55966196 |
140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55526281 |
141 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55495961 |
142 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54182435 |
143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54167935 |
144 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54110790 |
145 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.53869925 |
146 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53416254 |
147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53232972 |
148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52619165 |
149 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49122152 |
150 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43755266 |
151 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40877943 |
152 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.39934860 |
153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39536457 |
154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37953387 |
155 | Measles_Homo sapiens_hsa05162 | 0.37290562 |
156 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35508500 |
157 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.33073841 |